Immunovia Publ (Sweden) Probability of Future Stock Price Finishing Under 2.31
| IMMNOV Stock | SEK 0.88 0.03 3.53% |
Immunovia |
Immunovia Publ Target Price Odds to finish below 2.31
The tendency of Immunovia Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under kr 2.31 after 90 days |
| 0.88 | 90 days | 2.31 | close to 99 |
Based on a normal probability distribution, the odds of Immunovia Publ to stay under kr 2.31 after 90 days from now is close to 99 (This Immunovia publ AB probability density function shows the probability of Immunovia Stock to fall within a particular range of prices over 90 days) . Probability of Immunovia publ AB price to stay between its current price of kr 0.88 and kr 2.31 at the end of the 90-day period is about 7.19 .
Assuming the 90 days trading horizon the stock has the beta coefficient of 2.34 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Immunovia Publ will likely underperform. Additionally Immunovia publ AB has an alpha of 0.2307, implying that it can generate a 0.23 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Immunovia Publ Price Density |
| Price |
Predictive Modules for Immunovia Publ
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Immunovia publ AB. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Immunovia Publ Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Immunovia Publ is not an exception. The market had few large corrections towards the Immunovia Publ's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Immunovia publ AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Immunovia Publ within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.23 | |
β | Beta against Dow Jones | 2.34 | |
σ | Overall volatility | 0.13 | |
Ir | Information ratio | 0.04 |
Immunovia Publ Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Immunovia Publ for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Immunovia publ AB can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Immunovia publ AB is way too risky over 90 days horizon | |
| Immunovia publ AB has some characteristics of a very speculative penny stock | |
| Immunovia publ AB appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 844 K. Net Loss for the year was (166.63 M) with profit before overhead, payroll, taxes, and interest of 15.81 M. | |
| Immunovia publ AB has accumulated about 359.85 M in cash with (152.65 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 18.42, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 36.0% of the company shares are held by company insiders |
Immunovia Publ Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Immunovia Stock often depends not only on the future outlook of the current and potential Immunovia Publ's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Immunovia Publ's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 22.6 M | |
| Cash And Short Term Investments | 287.4 M |
Immunovia Publ Technical Analysis
Immunovia Publ's future price can be derived by breaking down and analyzing its technical indicators over time. Immunovia Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Immunovia publ AB. In general, you should focus on analyzing Immunovia Stock price patterns and their correlations with different microeconomic environments and drivers.
Immunovia Publ Predictive Forecast Models
Immunovia Publ's time-series forecasting models is one of many Immunovia Publ's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Immunovia Publ's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Immunovia publ AB
Checking the ongoing alerts about Immunovia Publ for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Immunovia publ AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Immunovia publ AB is way too risky over 90 days horizon | |
| Immunovia publ AB has some characteristics of a very speculative penny stock | |
| Immunovia publ AB appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 844 K. Net Loss for the year was (166.63 M) with profit before overhead, payroll, taxes, and interest of 15.81 M. | |
| Immunovia publ AB has accumulated about 359.85 M in cash with (152.65 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 18.42, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 36.0% of the company shares are held by company insiders |
Other Information on Investing in Immunovia Stock
Immunovia Publ financial ratios help investors to determine whether Immunovia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Immunovia with respect to the benefits of owning Immunovia Publ security.